Nektar Therapeutics (NKTR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.1700 |
| Open | 1.1300 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.1100 - 1.1600 |
| 52-week range | 0.4100 - 1.9300 |
| Volume | |
| Avg. volume | 2,243,085 |
| Market cap | 209.783M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9100 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.60 |
PR NewswireNektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
Nektar Therapeutics (Nasdaq: NKTR) today announced the presentation of a poster highlighting new preclinical data on NKTR-0165 at the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress.
Simply Wall St.Nektar Therapeutics' (NASDAQ:NKTR) investors will be pleased with their stellar 130% return over the last year
Nektar Therapeutics ( NASDAQ:NKTR ) shareholders might be concerned after seeing the share price drop 11% in the last...
- PR Newswire
Nektar Management to Present at Upcoming Investor Conferences
Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences:
© 2024 Yahoo. All rights reserved.